Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Total Liabilities: 2011-2025

Historic Total Liabilities for Abeona Therapeutics (ABEO) over the last 15 years, with Sep 2025 value amounting to $59.9 million.

  • Abeona Therapeutics' Total Liabilities fell 19.99% to $59.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.9 million, marking a year-over-year decrease of 19.99%. This contributed to the annual value of $64.9 million for FY2024, which is 31.97% up from last year.
  • Per Abeona Therapeutics' latest filing, its Total Liabilities stood at $59.9 million for Q3 2025, which was down 27.58% from $82.7 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Total Liabilities registered a high of $83.7 million during Q1 2024, and its lowest value of $23.3 million during Q3 2022.
  • For the 3-year period, Abeona Therapeutics' Total Liabilities averaged around $59.7 million, with its median value being $59.9 million (2025).
  • As far as peak fluctuations go, Abeona Therapeutics' Total Liabilities tumbled by 49.56% in 2022, and later surged by 141.90% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Total Liabilities (Quarterly) stood at $37.2 million in 2021, then increased by 0.63% to $37.5 million in 2022, then soared by 31.30% to $49.2 million in 2023, then soared by 31.97% to $64.9 million in 2024, then declined by 19.99% to $59.9 million in 2025.
  • Its Total Liabilities was $59.9 million in Q3 2025, compared to $82.7 million in Q2 2025 and $58.0 million in Q1 2025.